Every 1st Wednesday of the month at 12:30 PT Live Question and Answer session with Regenerative Experts
Non-Surgical Treatment of Tendon and Ligament Injuries using PRP and Cell Based therapy
Join us on our Free Facebook Live Series called Ask the Docs. In this session, SDOMG physician experts will answer your questions related to Non-Surgical Treatment of Tendon and Ligament Injuries using PRP and Cell Based therapy.
Join our free webinar to learn about PRP, an innovative non-surgical treatment option for osteoarthritis and other orthopedic conditions.
Dr. Mary Ambach specializes in non-surgical orthopedics, regenerative therapies, and interventional pain management. As a key thought leader in the field of Regenerative Medicine, Dr. Ambach conducts research, trains physicians, and lectures at international medical conferences.
Dr. Christopher Rogers is one of the world’s leading experts in orthopedic regenerative medicine and a renowned speaker at national medical conferences. He has developed new approaches for the treatment of tendon injuries, osteoarthritis, and disc degeneration which provide a safe and viable alternative to surgery.
Watch the webinar playback of Dr. Choll Kim, an internationally recognized Orthopedic Spine surgeon from the San Diego Spine Institute, who hosted an expert panel discussion with Dr. Christopher Rogers and Dr. Mary Ambach from the San Diego Orthobiologics Medical Group. Learn about innovative, non-surgical, and cell based therapies for patients with low back and neck pain.
On August 19, 2020, Dr. Christopher Rogers and Dr. Mary Ambach presented an education webinar on Neck & Low Back Pain: Using Your Own Cells to Heal your Body.
Neck and Low Back Pain Webinar
In this webinar, they discuss the causes of neck & low back pain, stem cell therapies, PRP therapies, and scientific research that provides evidence of safety and efficacy of these treatments. The in depth nature of this webinar is meant to be educational and provide people with knowledge and understanding of treatment options and what is available for specific types of chronic pain.
Dr. Christopher Rogers, founder of San Diego Orthobiologics Medical Group (SDOMG) and medical director for Personalized Stem Cells, Inc. (PSC), is pleased to announce that they have obtained FDA approval to treat patients with severe COVID-19 using stem cells.
In record time, Personalized Stem Cells, Inc. has received approval from the U.S. Food and Drug Administration to conduct a clinical trial of stem cells for the treatment of patients with severe COVID-19 (1). Stem cell therapy has already shown encouraging results in studies conducted in Spain, Israel, and China. Dr. Rogers and his coauthors recently published a landmark peer-reviewed scientific article on the rationale behind the use of stem cells to treat COVID-19 (2). Support from entire team at SDOMG and PSC was critical to achieving this exciting accomplishment. We are eager to initiate this clinical trial and demonstrate the safety and efficacy of this innovative and promising therapy.
DR. CHRISTOPHER ROGERS PRESENTS THE NON-SURGICAL OPTIONS TO JOINT REPLACEMENT AT A LIVE, WORLD-WIDE BROADCAST.
As an expert in the field of Regenerative Medicine, Dr. Rogers was invited to share his experience and the scientific evidence for the treatment of joint pain. Joint Replacement Awareness Day (JRAD) is an annual event sponsored by BoneSmart®, a worldwide patient engagement platform that brings awareness, education and support to patients throughout their entire joint replacement journey. More than 1.5 million Americans undergo joint replacement each year for painful osteoarthritis, yet most patients prefer to avoid surgery when possible. Treatment with Orthobiologics such as platelet rich plasma (PRP) and other cell based therapies are a safe and effective option for patients wishing to avoid or delay joint replacement surgery.
